Gene expression profiling in melanoma: A view from the clinic

Whiteman, 2015, More people die from thin melanomas (1 mm) than from thick melanomas (>4 mm) in Queensland, Australia. J Invest. Dermatol., 135, 1190, 10.1038/jid.2014.452 Greenhaw, 2020, Molecular risk prediction in cutaneous melanoma: a meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients, J Am Acad. Dermatol., 83, 745, 10.1016/j.jaad.2020.03.053 Amaral, 2020, Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma, Eur. J. Cancer, 125, 38, 10.1016/j.ejca.2019.10.027 Grossman, 2019, Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice, Melanoma Manag., 6, 10.2217/mmt-2019-0016 2019, Cutaneous Melanoma - Version 2.2019, in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), NCCN: nccn.org Moody, 2017, Complications of sentinel lymph node biopsy for melanoma – a systematic review of the literature, Eur. J. Surg. Oncol.(EJSO), 43, 270, 10.1016/j.ejso.2016.06.407 Sinnamon, 2017, Predictors of false negative sentinel lymph node biopsy in trunk and extremity melanoma, J. Surg. Oncol., 116, 848, 10.1002/jso.24743 Mulder, 2020, Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma, Br. J. Dermatol. Hawryluk, 2012, Histologically challenging melanocytic tumors referred to a tertiary care pigmented lesion clinic, J. Am. Acad. Dermatol., 67, 727, 10.1016/j.jaad.2012.02.036 Clarke, 2017, An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi, Cancer, 123, 617, 10.1002/cncr.30385